These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1152 related items for PubMed ID: 12029550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL, Rodríguez Rodríguez JR, Borrego Dorado I, Navarro González E, Tirado Hospital JL, Vázquez Albertino R.
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [Abstract] [Full Text] [Related]

  • 4. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
    Mariani G, Ferdeghini M, Augeri C, Villa G, Taddei GZ, Scopinaro G, Boni G, Bodei L, Rabitti C, Molinari E, Bianchi R.
    Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
    [Abstract] [Full Text] [Related]

  • 5. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP.
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [Abstract] [Full Text] [Related]

  • 6. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P, Gallowitsch HJ.
    Acta Med Austriaca; 1996 Jan; 23(1-2):69-75. PubMed ID: 8767519
    [Abstract] [Full Text] [Related]

  • 7. Follow-up of differentiated thyroid cancer.
    Pacini F.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
    [Abstract] [Full Text] [Related]

  • 8. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A.
    J BUON; 2006 Aug; 11(4):511-8. PubMed ID: 17309186
    [Abstract] [Full Text] [Related]

  • 9. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer.
    Roelants V, Nayer PD, Bouckaert A, Beckers C.
    Eur J Nucl Med; 1997 Jul; 24(7):722-7. PubMed ID: 9211756
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.
    Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1499-501. PubMed ID: 11932271
    [Abstract] [Full Text] [Related]

  • 11. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Oyen WJ, Verhagen C, Saris E, van den Broek WJ, Pieters GF, Corsten FH.
    J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
    [Abstract] [Full Text] [Related]

  • 12. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels.
    Pachón-Garrudo VM, Cuenca-Cuenca JI, Ruiz-Franco-Baux J, Borrego-Dorado I, Tirado-Hospital JL, Navarro-González E, Vázquez-Albertino R.
    Rev Esp Med Nucl Imagen Mol; 2012 Apr; 31(6):315-21. PubMed ID: 23084014
    [Abstract] [Full Text] [Related]

  • 13. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [Abstract] [Full Text] [Related]

  • 14. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM, Kim ES, Ryu JS, Hong SJ, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [Abstract] [Full Text] [Related]

  • 15. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Salvatori M, Perotti G, Rufini V, Maussier ML, Dottorini M.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
    [Abstract] [Full Text] [Related]

  • 16. [Application of recombinant human TSH in the diagnostic protocol of differentiated thyroid carcinoma].
    Jiménez-Hoyuela García JM, García Almeida JM, Delgado García A, Aguilar Fernández I, Martínez del Valle Torres MD, Ortega Lozano S, Rebollo Aguirre A, Mancha Doblas I, Pinzón Martín JL, Picón César MJ, Zamorano Vázquez D.
    Rev Esp Med Nucl; 2005 Dec; 24(3):152-60. PubMed ID: 15847782
    [Abstract] [Full Text] [Related]

  • 17. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
    Ma C, Xie J, Kuang A.
    J Nucl Med; 2005 Jul; 46(7):1164-70. PubMed ID: 16000286
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G.
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [Abstract] [Full Text] [Related]

  • 19. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 20. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD, Kao PF, Chao TC.
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.